Long-term safety and efficacy of sepetaprost, with or without timolol, in patients with open-angle glaucoma or ocular hypertension: results from the randomised, phase 3 ANGEL-J2 study

Masaru Inatani, Yuko Tone, Toshihiro Ikeda, Raymund Angeles

Open source

DOI
10.1007/s10384-026-01351-2
Published
2026-06-16
Container
Japanese Journal of Ophthalmology
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s10384-026-01351-2,
  title = {Long-term safety and efficacy of sepetaprost, with or without timolol, in patients with open-angle glaucoma or ocular hypertension: results from the randomised, phase 3 ANGEL-J2 study},
  author = {Masaru Inatani and Yuko Tone and Toshihiro Ikeda and Raymund Angeles},
  year = {2026},
  journal = {Japanese Journal of Ophthalmology},
  doi = {10.1007/s10384-026-01351-2},
  url = {https://doi.org/10.1007/s10384-026-01351-2}
}

RIS

TY  - JOUR
TI  - Long-term safety and efficacy of sepetaprost, with or without timolol, in patients with open-angle glaucoma or ocular hypertension: results from the randomised, phase 3 ANGEL-J2 study
AU  - Masaru Inatani
AU  - Yuko Tone
AU  - Toshihiro Ikeda
AU  - Raymund Angeles
PY  - 2026
JO  - Japanese Journal of Ophthalmology
DO  - 10.1007/s10384-026-01351-2
UR  - https://doi.org/10.1007/s10384-026-01351-2
ER  - 

APA

Inatani, M., Tone, Y., Ikeda, T., & Angeles, R. (2026). Long-term safety and efficacy of sepetaprost, with or without timolol, in patients with open-angle glaucoma or ocular hypertension: results from the randomised, phase 3 ANGEL-J2 study. Japanese Journal of Ophthalmology. https://doi.org/10.1007/s10384-026-01351-2

Source records